These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8491515)
1. Swine as a model of skin inflammation. Phospholipase A2-induced inflammation. Nair X; Nettleton D; Clever D; Tramposch KM; Ghosh S; Franson RC Inflammation; 1993 Apr; 17(2):205-15. PubMed ID: 8491515 [TBL] [Abstract][Full Text] [Related]
2. Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents. Marshall LA; Chang JY; Calhoun W; Yu J; Carlson RP J Cell Biochem; 1989 Jun; 40(2):147-55. PubMed ID: 2768346 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. Pruzanski W; Vadas P; Fornasier V J Invest Dermatol; 1986 Apr; 86(4):380-3. PubMed ID: 3745958 [TBL] [Abstract][Full Text] [Related]
4. Chymopapain-induced reduction of proinflammatory phospholipase A2 activity and amelioration of neuropathic behavioral changes in an in vivo model of acute sciatica. Sawin PD; Traynelis VC; Rich G; Smith BA; Maves TJ; Follett KA; Moore SA J Neurosurg; 1997 Jun; 86(6):998-1006. PubMed ID: 9171179 [TBL] [Abstract][Full Text] [Related]
5. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2. Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313 [TBL] [Abstract][Full Text] [Related]
7. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Vadas P; Pruzanski W; Kim J; Fornasier V Am J Pathol; 1989 Apr; 134(4):807-11. PubMed ID: 2705507 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human type II phospholipase A2 lacks edema producing activity in rat. Morgan DW; Anderson CM; Meyers KP Eur J Pharmacol; 1993 Apr; 235(1):45-50. PubMed ID: 8519280 [TBL] [Abstract][Full Text] [Related]
9. Edema formation and degranulation of mast cells by a basic phospholipase A2 purified from Trimeresurus mucrosquamatus snake venom. Chiu HF; Chen IJ; Teng CM Toxicon; 1989; 27(1):115-25. PubMed ID: 2469141 [TBL] [Abstract][Full Text] [Related]
10. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565 [TBL] [Abstract][Full Text] [Related]
11. The role of steroids and their effects on phospholipase A2. An animal model of radiculopathy. Lee HM; Weinstein JN; Meller ST; Hayashi N; Spratt KF; Gebhart GF Spine (Phila Pa 1976); 1998 Jun; 23(11):1191-6. PubMed ID: 9636970 [TBL] [Abstract][Full Text] [Related]
12. The edema inducing activity of phospholipase A2 enzymes. Tan NH; Saifuddin MN; Yong WY Biochem Int; 1991 Jan; 23(1):175-81. PubMed ID: 1863271 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity. Marks R; Sawyer M Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouse. Calhoun W; Yu J; Sung A; Chau TT; Marshall LA; Weichman BM; Carlson RP Agents Actions; 1989 Jun; 27(3-4):418-21. PubMed ID: 2801333 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antiinflammatory and antiallergic drugs in the melittin- and D49 PLA2-induced mouse paw edema models. Hartman DA; Tomchek LA; Lugay JR; Lewin AC; Chau TT; Carlson RP Agents Actions; 1991 Sep; 34(1-2):84-8. PubMed ID: 1793058 [TBL] [Abstract][Full Text] [Related]
16. Effects of copper, iron and zinc on oedema formation induced by phospholipase A2. Ferrer X; Moreno JJ Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Jun; 102(2):325-7. PubMed ID: 1358548 [TBL] [Abstract][Full Text] [Related]
17. Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities. Landucci EC; Castro RC; Pereira MF; Cintra AC; Giglio JR; Marangoni S; Oliveira B; Cirino G; Antunes E; De Nucci G Eur J Pharmacol; 1998 Feb; 343(2-3):257-63. PubMed ID: 9570475 [TBL] [Abstract][Full Text] [Related]
18. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421 [TBL] [Abstract][Full Text] [Related]
19. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290 [TBL] [Abstract][Full Text] [Related]
20. Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Vishwanath BS; Fawzy AA; Franson RC Inflammation; 1988 Dec; 12(6):549-61. PubMed ID: 3220517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]